NNIT in Switzerland Relocates to New Modern Office in the Center of Basel
After more than 14 years at the same location in Switzerland, NNIT has relocated to Grosspeter Tower, an impressive 21-storey structure in the city of Basel.
After more than 14 years at the same location in Switzerland, NNIT has relocated to Grosspeter Tower, an impressive 21-storey structure in the city of Basel.
The life sciences market in Europe is idling – even hesitant – following the macro-economic and geo-political hits of war, energy crisis, inflation, increasing interest rates and increasing EU regulation. But Ricco Larsen, Senior Vice President of Life Sciences Europe at NNIT, remains positive based on a firm belief in the resilience of the industry.
Revenue growth of 12.2%, an operating profit margin of 5.2% – and full-year financial outlook maintained.
Together with Astralis, we are currently exploring insights from game studies as an alternative to traditional e-learning for public IT systems, considering both the case handler and citizen perspectives.
NNIT’s Migration Powerhouse, renowned for its expertise in critical data migrations where compliance and accuracy are paramount, is proud to announce the launch of the latest iteration of its flagship software, Valiance TRUseries 5.0.
A new global structure dedicated to AI and led by Director Sam Laermans has been created to ensure unity, best practice, and maximum utilization of expertise and resources across our four regional AI business units.
Our China head office has relocated from Tianjin Jinwan Mansion to Tianjin Luneng International Center to provide employees with a more convenient and flexible office environment as well as better surroundings for the collaboration with our customers and partners.
More than 400 talented and ambitious young people were nominated for this year's Talent 100 published by Berlingske. Only 100 talents were ultimately selected for this year’s list, and Marina Prodan is one of them.
NNIT completes successful collaboration with a Top 20 Biopharma pioneer in transitioning to a new Electronic Data Capture (EDC) platform for their clinical trials.
NNIT’s headquarters will be relocating from Oestmarken 3A in Soeborg to Weidekampsgade 14 in downtown Copenhagen to become better connected to customers and partners and provide employees with a more inviting and open office environment.
Every year, alongside our annual report, we issue a Sustainability Report (COP report), outlining the progress and direction of our sustainability activities.
Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
The Group improved business and financial performance throughout the year and delivered on the outlook, which was upgraded in August, 2023.
Artificial intelligence (AI) has moved into the public sector, and the Danish authorities are exploring how the technology can become a valuable tool. According to NNIT's Jannic Stolzenbach Jensen, transparency and human supervision will be crucial in ensuring that AI can improve welfare.
Like the rest of the world, the life sciences industry is right in the eye of a raging storm of multiple rapid changes. According to Ricco Larsen, Senior Vice President at NNIT, the top priority for pharma companies is to invest in a solid data foundation so they are fully prepared for what comes next.
The potential benefits of an electronic Trial Master File (eTMF) system extend far beyond clinical operations. As Tróndur Ellingsgaard, Advisory Consultant at NNIT explains, a mature eTMF can enhance efficiency, foster greater collaboration across the organization, and enable informed decision-making.
Everest Group has just released its Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024 (part of the Life Sciences Information Technology research program), and we are proud to announce that NNIT features among the Leaders.
Life science organizations face complex regulatory challenges, intensive audits, and robust internal process controls. With this new partnership, NNIT and Gimmal provide a well-established, compliant solution that customers operating within life sciences can rely on to manage the information lifecycle of GxP records.
As NNIT expands its presence in the United States, particularly with the anticipated integration of Excellis Health Solutions (Excellis), Greg Cathcart, Head of Excellis, will assume the lead role of Senior Vice President to accelerate growth and advance the market position in the US.
Implementing an electronic Trial Master File (eTMF) system can revolutionize the way clinical trials are managed. However, as Michael Agard, Director of Clinical Consulting at NNIT, points out, the true value of eTMF lies in post-implementation management.